Enhanced expression of Fas ligand (FasL) in fibrotic interstitial lung diseases (ILDs). The possible role of membrane-bound FasL form

P. Kopinski, A. Dyczek, B. Balicka-Slusarczyk, G. Przybylski, J. Chorostowska-Wynimko, A. Szpechcinski, T. Iwaniec, K. Szablowska, J. Szczeklik (Bydgoszcz, Kracow, Warsaw, Poland)

Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Session: Genetic and molecular background in pulmonary fibrosis
Session type: Poster Discussion
Number: 2002
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Kopinski, A. Dyczek, B. Balicka-Slusarczyk, G. Przybylski, J. Chorostowska-Wynimko, A. Szpechcinski, T. Iwaniec, K. Szablowska, J. Szczeklik (Bydgoszcz, Kracow, Warsaw, Poland). Enhanced expression of Fas ligand (FasL) in fibrotic interstitial lung diseases (ILDs). The possible role of membrane-bound FasL form. Eur Respir J 2011; 38: Suppl. 55, 2002

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis
Source: Eur Respir J 2005; 26: Suppl. 49, 542s
Year: 2005

Expression and clinical importance of Fas/Fas ligand system in interstitial lung diseases (ILD)
Source: Eur Respir J 2006; 28: Suppl. 50, 745s
Year: 2006

The role of TNF-related apoptosis inducing ligand (TRAIL) in fibrotic lung disease
Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both?
Year: 2011

Expression and function of Fas receptor (CD95) and Fas ligand (FasL) on T cells in atopic bronchial asthma (ABA): the role of glucocorticoid (GC)-therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 581s
Year: 2005

Resistance of BAL immune cells to apoptosis in interstitial lung diseases (ILD) with high local tumor necrosis factor-α (TNFα) levels as a possible consequence of common TNF receptor type 2 expression
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008


The death receptors (DRs) expressed on alveolar lymphocytes (AL) in interstitial lung diseases (ILD) participate in apoptosis regulation
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012

The death receptor CD95 (Fas, Apo-1) expression and Annexin-V binding of phosphatidylserine in lymphocytes in bronchial asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 757s
Year: 2006

Interferon-gamma (IFN-γ) alters the expression of IP-10 and IL-18 in human aveolar epithelial cells type II. Possible role in the reinforcement of Th1-dominated lung inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 521s
Year: 2001

Differential expression of stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular disease: a bronchoalveolar la
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

Expression of angiogenic growth factors and stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis in idiopathic pulmonary fibrosis: a lung tissue study
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008


Altered expression of toll-like receptor (TLR)-2 and TLR-4 on alveolar macrophages (AM) in inflammatory lung disease
Source: Eur Respir J 2003; 22: Suppl. 45, 588s
Year: 2003

Decreased apoptotic rate of alveolar macrophages of patients with idiopathic pulmonary fibrosis is not associated with difference in expression of fas or fas ligand
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008

Low apoptosis rate as a reason of local immune cell accumulation in interstitial lung diseases (ILD). The role of cytokine network
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006

Alveolar recruited macrophages contribute to lung epithelial apoptosis and barrier dysfunction by expression of TNF-related apoptosis-inducing ligand during influenza virus pneumonia
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008

Elevated integrin ?5 expression in idiopathic pulmonary fibrosis (IPF) derived fibroblasts is linked to paracrine TNF-a signaling
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017

Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 17: 180-189
Year: 2001



Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation
Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis
Year: 2006


Role of TNF-related apoptosis inducing ligand (TRAIL) in lung protective immunity against S. pneumoniae
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010

αVβ6 integrin expression in interstitial lung diseases
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009


Elevated serum B cell activating factor belonging to the TNF family (BAFF) in interstitial lung diseases associated with collagen vascular disease
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012